D.L. Venton

13-Azaprostanoic acid: a specific antagonist of the human blood platelet thromboxane/endoperoxide receptor.

Guy C. Le Breton, D.L. Venton, Steven E. Enke et al. · Proceedings of the National Academy of Sciences · 1979 · 114 citations · Full text

Specific Antagonist, 13-Aza Derivative, Prostanoic Acid +20

Characterization of U46619 binding in unactivated, intact human platelets and determination of binding site affinities of four TXA2/PGH2 receptor antagonists (13-APA, BM 13.177, ONO 3708 and SQ 29,548)

E.J. Kattelman, D.L. Venton, Guy C. Le Breton · Thrombosis Research · 1986 · 108 citations

Molecular Pharmacology, Thrombosis, Biochemistry +11

Enrichment of platelet phospholipids with eicosapentaenoic acid and docosahexaenoic acid inhibits thromboxane A2/prostaglandin H2 receptor binding and function.

Patrick G. Swann, Carole A. Parent, Martine Croset et al. · Journal of Biological Chemistry · 1990 · 69 citations · Full text

Lipid Analysis, Platelet Aggregation, Linoleic Acid +19

Arachidonic acid-induced platelet aggregation is mediated by a thromboxane A2/prostaglandin H2 receptor interaction.

Leslie V. Parise, D.L. Venton, Guy C. Le Breton · Journal of Pharmacology and Experimental Therapeutics · 1984 · 66 citations

High-yielding synthesis of monoalkylhydrazines

N. I. GHALI, D.L. Venton, S. C. Hung et al. · The Journal of Organic Chemistry · 1981 · 50 citations

Combinatorial Chemistry, Molecular Sciences, Altmetric Attention Score +10